Plasma CAF22, a Biomarker of Neuromuscular Junction Integrity, is Associated with Risk and Earlier Onset of Statin-Associated Muscle Symptoms.
- DOI
- 10.1007/s10557-026-07982-4
- Published
- 2026 Nov 9
- Container
- Cardiovascular drugs and therapy
- Publisher
- Not recorded
- Open access
- unknown
Credibility signals
limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1007/s10557-026-07982-4,
title = {Plasma CAF22, a Biomarker of Neuromuscular Junction Integrity, is Associated with Risk and Earlier Onset of Statin-Associated Muscle Symptoms.},
author = {Qaisar R and Iqbal MS and Karim A and Ahmad F},
year = {2026},
journal = {Cardiovascular drugs and therapy},
doi = {10.1007/s10557-026-07982-4},
url = {https://doi.org/10.1007/s10557-026-07982-4}
}RIS
TY - JOUR TI - Plasma CAF22, a Biomarker of Neuromuscular Junction Integrity, is Associated with Risk and Earlier Onset of Statin-Associated Muscle Symptoms. AU - Qaisar R AU - Iqbal MS AU - Karim A AU - Ahmad F PY - 2026 JO - Cardiovascular drugs and therapy DO - 10.1007/s10557-026-07982-4 UR - https://doi.org/10.1007/s10557-026-07982-4 ER -
APA
R, Q., MS, I., A, K., & F, A. (2026). Plasma CAF22, a Biomarker of Neuromuscular Junction Integrity, is Associated with Risk and Earlier Onset of Statin-Associated Muscle Symptoms.. Cardiovascular drugs and therapy. https://doi.org/10.1007/s10557-026-07982-4
Source records
- pubmed · retrieved 2026-11-10T09:50:53.796Z